SC
NVO

Sepio Capital’s Novo Nordisk NVO Stock Holding History

Sepio Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.73M Buy
36,095
+669
+2% +$28.7K 0.09% 121
2026
Q1 		$1.3M Buy
35,426
+2,918
+9% +$138K 0.07% 148
2025
Q4 		$1.65M Sell
32,508
-1,079
-3% -$55.2K 0.09% 125
2025
Q3 		$1.86M Buy
33,587
+6,196
+23% +$363K 0.11% 114
2025
Q2 		$1.89M Buy
27,391
+32
+0.1% +$2.18K 0.13% 107
2025
Q1 		$1.9M Buy
27,359
+7,455
+37% +$616K 0.15% 108
2024
Q4 		$1.71M Sell
19,904
-138
-0.7% -$14.9K 0.14% 119
2024
Q3 		$2.39M Sell
20,042
-154
-0.8% -$20.5K 0.19% 98
2024
Q2 		$2.88M Sell
20,196
-78
-0.4% -$10.3K 0.26% 79
2024
Q1 		$2.6M Sell
20,274
-1,970
-9% -$235K 0.22% 92
2023
Q4 		$2.3M Sell
22,244
-3,461
-13% -$342K 0.19% 95
2023
Q3 		$2.34M Buy
25,705
+319
+1% +$28.1K 0.2% 103
2023
Q2 		$2.05M Sell
25,386
-1,016
-4% -$83K 0.17% 144
2023
Q1 		$2.1M Sell
26,402
-4,054
-13% -$287K 0.19% 137
2022
Q4 		$2.06M Sell
30,456
-4,628
-13% -$271K 0.18% 147
2022
Q3 		$1.75M Sell
35,084
-1,404
-4% -$75.2K 0.17% 143
2022
Q2 		$2.03M Sell
36,488
-1,204
-3% -$66.8K 0.2% 138
2022
Q1 		$2.09M Sell
37,692
-2,666
-7% -$137K 0.18% 151
2021
Q4 		$2.26M Buy
40,358
+92
+0.2% +$4.98K 0.17% 161
2021
Q3 		$1.93M Buy
40,266
+188
+0.5% +$9.09K 0.16% 170
2021
Q2 		$1.68M Sell
40,078
-4,590
-10% -$178K 0.14% 188
2021
Q1 		$1.51M Buy
+44,668
New +$1.59M 0.14% 184
2019
Q3 		– Sell
-143,208
Closed -$3.65M – 269
2019
Q2 		$3.65M Sell
143,208
-704
-0.5% -$17.4K 0.49% 61
2019
Q1 		$3.76M Sell
143,912
-19,720
-12% -$485K 0.51% 55
2018
Q4 		$3.77M Buy
+163,632
New +$3.64M 0.27% 68

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Sepio Capital's NVO Position: Q2 2026 in Review

Sepio Capital increased its Novo Nordisk (NVO) stake by 1.9% in Q2 2026, buying an estimated $28.7K and bringing the position to 36,095 shares worth $1.73M. The position accounts for 0.09% of the portfolio, ranked #121.

Sepio Capital first reported a position in NVO in Q4 2018 and has held it in 25 quarters since. The position peaked at $3.77M in Q4 2018. 1,355 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Sepio Capital held 36,095 shares of Novo Nordisk worth $1.73M as of Q2 2026.
  • Sepio Capital bought 669 Novo Nordisk shares in Q2 2026, an estimated $28.7K.
  • Novo Nordisk made up 0.09% of Sepio Capital's portfolio in Q2 2026, its #121 holding.
  • Sepio Capital first reported a position in Novo Nordisk in Q4 2018 and has held it in 25 quarters since.
  • Sepio Capital's Novo Nordisk position peaked at $3.77M in Q4 2018.
  • 1,355 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Sepio Capital's 13F filing for Q2 2026, filed 28 Jul 2026.